References and Recommended Reading
American Psychiatric Association:Appendix C, Glossary of Technical Terms Diagnostic and Statistical Manual of Mental Disorders, Washington, DC: American Psychiatric Association; 1994:819–828.
Arciniegas DB:A clinical overview of pseudobulbar affect.Am J Geriatr Pharmacother 2005,3A:4–8.
Arciniegas DB, Topkoff J:The neuropsychiatry of pathological effect: an approach to evaluation and treatment.Semin Clin Neuropsychiatry 2000,5:290–306.
Of major importance Schiffer R, Pope LE:Review of pathological affect including a novel and potential therapy.J Neuropsychiatry Clin Neurosci 2005,14:447–454. This article offers the most detailed review of the epidemiology of PLC published to date.
Robinson RG, Parikh RM, Lipsey JR, et al.:Pathological laughing and crying following stroke: validation of a measurement scale and a double blind treatment study.Am J Psychiatry 1993,150:286–293.
Wilson SAK:Some problems in neurology. II. Pathological laughing and crying.J Neurol Psychopathol 1924,16:299–333.
Arciniegas DB, Lauterbach EC, Anderson KE, et al.:The differential diagnosis of pseudobulbar affect (PBA): distinguishing PBA among disorders of mood and affect. Proceedings of a roundtable meeting.CNS Spectr 2005,10:1–14.
Poeck K:Pathophysiology of emotional disorders associated with brain damage. InHandbook of Clinical Neurology,vol 3. Edited by Vinken P, Bruyn G. Amsterdam: North-Holland Publishing Co.; 1969:343–367.
Green RL, Bernat JL:Pathological crying. InMovement Disorders in Neurology and Neuropsychiatry. Edited by Joseph AB, Young RR. Oxford: Blackwell Science Inc.; 1999:352–359.
Luciano D, Devinsky O, Perrine K:Crying seizures.Neurology 1993,43:2113–2117.
Sackeim HA, Greenberg MS, Weiman AL, et al.: Hemispheric asymmetry in the expression of positive and negative emotions: neurological evidence.Arch Neurol 1982,39:210–218.
Pearce JM:A note on gelastic epilepsy.Eur Neurol 2004,52:172–174.
Of major importance Rabins PV, Arciniegas DB:Pathophysiology of involuntary emotional expression disorder.CNS Spectr 2007,12(Suppl 5):17–22. This article offers the most detailed review of the neuroanatomy and neurochemistry of PLC published to date.
Loeb C, Poggio GF:Neural substrates of memory, affective functions, and conscious experience.Adv Anat Embryol Cell Biol 2002,166:1–111.
Quirk GJ, Gehlert DR:Inhibition of the amygdala: key to pathological states?.Ann N Y Acad Sci 2003,985:263–272.
Zhu JN, Yung WH, Kwok-Chong CB, et al.:The cerebellar-hypothalamic circuits: potential pathways underlying cerebellar involvements in somatic-visceral integration.Brain Res Rev 2006,52:93–106.
Newsom-Davis IC, Abrahams S, Goldstein LH, Leigh PN:The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis.J Neurol Sci 1999,169:22–25.
Harvey PD, Greenberg BR, Serper MR:The affective lability scale: development, reliability, and validity.J Clin Psychol 1989,45:786–793.
Moore SR, Gresham LS, Bromberg MB, et al.:A self report measure of affective lability.J Neurol Neurosurg Psychiatry 1997,63:89–93.
Miller A:Pseudobulbar affect in multiple sclerosis: toward the development of innovative therapeutic strategies.J Neurol Sci 2006,245:153–159.
Of major importance Panitch HS, Thisted RA, Smith RA, et al.:Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.Ann Neurol 2006,9:780–787. This randomized, controlled trial merits review and consideration by clinicians using DM/Q for the treatment of PLC attributed to MS or any other cause.
Seliger GM, Hornstein A, Flax J, et al.:Fluoxetine improves emotional incontinence.Brain Inj 1992,6:267–270.
Sloan RL, Brown KW, Pentland B:Fluoxetine as a treatment for emotional lability after brain injury.Brain Inj 1992,6:315–319.
Nahas Z, Arlinghaus KA, Kotria KJ, et al.:Rapid response of emotional incontinence to selective serotonin reuptake inhibitors.J Neuropsychiatry Clin Neurosci 1998,10:453–455.
Seliger GM, Hornstein A:Serotonin, fluoxetine, and pseudobulbar affect.Neurology 1989,39:1400.
Burns A, Russell E, Stratton-Powell H, et al.:Sertraline in stroke-associated lability of mood.Int J Geriatr Psychiatry 1999,14:681–685.
Mukand J, Kaplan M, Senno RG, et al.:Pathological crying and laughing: treatment with sertraline.Arch Phys Med Rehabil 1996,77:1309–1311.
Benedek DM, Peterson KA:Sertraline for treatment of pathological crying.Am J Psychiatry 1995,152:953–954.
Muller U, Murai T, Bauer-Wittmund T, von Cramon DY:Paroxetine versus citalopram treatment of pathological crying after brain injury.Brain Inj 1999,13:805–811.
Derex L, Ostrowsky K, Nighoghossian N, et al.:Severe pathological crying after left anterior choroidal artery infarct: reversibility with paroxetine treatment.Stroke 1997,28:1464–1466.
Jeret JS:Treatment of poststroke pathological crying.Stroke 1997,28:2321–2322.
Anderson G, Vestergaard K, Riis JO:Citalopram for post-stroke pathological crying.Lancet 1993,342:837–839.
Iannaccone S, Ferini-Strambi L:Pharmacologic treatment of emotional lability.Clin Neuropharmacol 1996,19:532–535.
Schiffer RB, Herdon RM, Rudick RA:Treatment of pathological laughing and weeping with amitriptyline.N Engl J Med 1985,312:1480–1482.
Lawson IR, Macleod DM:The use of imipramine (“Tofranil”) and other psychotropic drugs in organic emotionalism.Br J Psychiatry 1969,115:281–285.
Wolf JK, Santana HB, Thorpy M:Treatment of “emotional incontinence” with levodopa.Neurology 1979,29:1435–1436.
Udaka F, Yamao S, Nagata H, et al.:Pathologic laughing and crying treated with levodopa.Neurology 1984,41:1095–1096.
Brooks BR, Thisted SH, Appel WG, et al.:Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial.Neurology 2004,63:1364–1370.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wortzel, H.S., Anderson, C.A. & Arciniegas, D.B. Treatment of pathologic laughing and crying. Curr Treat Options Neurol 9, 371–380 (2007). https://doi.org/10.1007/BF02938544
Issue Date:
DOI: https://doi.org/10.1007/BF02938544